Background: Transcatheter aortic valve replacement (TAVR) is standard therapy for patients
with severe aortic stenosis who are at high surgical risk. However, national data regarding …

Objectives: This study describes the characteristics of a real-world Asian patient population
treated with transcatheter aortic valve replacement (TAVR) and evaluates their clinical …

Background: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative
to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the …

Aims Transcatheter aortic valve replacement (TAVR) as an alternative to surgical aortic
valve replacement (SAVR) has profoundly changed the management of patients with aortic …

Background: Transcatheter aortic valve replacement (TAVR) has revolutionized
management of high-risk patients with severe aortic stenosis. However, survival and the …

Objectives: The authors sought to examine the adoption of transcatheter aortic valve
replacement (TAVR) in Western Europe and investigate factors that may influence the …

Background: Transcatheter aortic valve replacement (TAVR) has evolved into a routine
procedure with good outcomes in high-risk patients. Objectives: TAVR complication rates …

Importance Transcatheter aortic valve replacement (TAVR) was approved by the US Food
and Drug Administration for the treatment of severe, symptomatic aortic stenosis and …

Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

Abstract Objectives: The UK Transcatheter Aortic Valve Implantation Registry reported 30-
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …